Clarivate’s public access page offers Johnson & Johnson employees access. This is an access relationship, not a seat count or evidence of individual use.
Pharmaceutical competitive intelligence starts with a question
Pipeline research, clinical development, commercial assessment, and vendor intelligence describe different work. Choose the question before choosing a database or a consulting service. The directory separates product descriptions from observed company relationships.
Our company evidence includes enterprise workflows at AstraZeneca, SAP systems at Roche, and a public Cortellis access page for Johnson & Johnson employees. These do not establish which teams use every tool or how much they spend.
Healthcare intelligence services and consultants
Evaluate a service around its research coverage, source traceability, update cadence, and the decision it is meant to support. Ask whether the engagement delivers source records, interpretation, or both. The listed services are not ranked by quality and no prices are estimated.
Clarivate’s employee access page supports an available research relationship, not evidence of individual usage. Citeline and Evaluate descriptions come from official pages; we have not established their customer populations.
What a pharma vendor stack can tell you
The observed stack is partial. An ERP or employee workflow observation does not reveal drug-development strategy. A planned deployment in a customer story must be kept separate from systems already described as running.
For a competitive brief, record the company, service scope, publication context, and review date. Keep any interpretation separate from those observations.
A public job board supports an ATS observation. A subprocessor disclosure identifies a provider that may process data for particular services. A vendor customer story describes a published relationship. These sources have different scopes and are labeled separately.
Counts cover the records on these pages, not the whole market. No observation in our covered sources does not mean a company does not use a vendor. Source recency and unresolved conflicts affect confidence; observations do not establish spend, renewal timing, or customer churn.